Pfizer (NYSE: PFE), the US pharmaceutical powerhouse, has signed a strategic memorandum of understanding with the People’s Government of Guangdong Municipality to collaborate on various initiatives within the biomedicine sector. This partnership will focus on research and development innovation, R&D translation, and talent cultivation, with the overarching goal of enhancing the biomedicine and healthcare industries in the region.
While the details of the collaboration remain undisclosed, the agreement underscores Pfizer’s commitment to advancing biomedicine in Guangdong, a key area for growth in China’s healthcare landscape.- Flcube.com
